The full IPO calendar is available at IPOpremium.com
Ranked by size of IPO, largest first.
(1) Based in Troy, MI, Talmer Bancorp (TLMR) scheduled a $210 million IPO on the Nasdaq with a market capitalization of $1 billion at a price range midpoint of $13.50 for Wednesday, February 12, 2014.
Between April 30, 2010 and December 31, 2013, TLMR successfully completed five community bank acquisitions totaling $5 billion in assets and $4.9 billion in liabilities.
(2) Based in Columbus, OH,Installed Building Products (IBP) scheduled a $135 million IPO on the NYSE with a market capitalization of $432 million at a price range midpoint of $15 for Thursday, February 13, 2014.
IBP is the second largest new residential insulation installer in the United States based on its internal estimates, with a national platform consisting of over 100 locations serving customers in 44 states.
(3) Based in Goleta, CA, Inogen (INGN) scheduled a $75 million IPO on the Nasdaq with a market capitalization of $306 million at a price range midpoint of $17 for Friday, February 14, 2014.
INGN believes it is the only portable oxygen concentrator manufacturer that employs a direct-to-consumer marketing strategy in the United States
(4) Based in Lexington, MA, Concert Pharmaceuticals (CNCE) scheduled a $65 million IPO on the Nasdaq with a market capitalization of $211 million at a price range midpoint of $13 for Friday, February 14, 2014.
CNCE is a clinical stage biopharmaceutical company applying its extensive knowledge of deuterium chemistry to discover and develop novel small molecule drugs.
(5) Based in Burlington, MA, Flexion Therapeutics (FLXN) scheduled a $65 million IPO on the Nasdaq with a market capitalization of $192 million at a price range midpoint of $13 for Wednesday, February 12, 2014.
FLXN is a specialty pharmaceutical company focused on the development and commercialization of novel, long-acting, injectable pain therapies. FLXN is In Phase 2 clinical trials.
(6) Based in Woodcliff Lake, NJ, Eagle Pharmaceuticals (EGRX) scheduled a $50 million IPO on the Nasdaq with a market capitalization of $209 million at a price range midpoint of $15 for Thursday, February 13, 2014.
EGRX is a specialty pharmaceutical company focused on developing and commercializing injectable products utilizing the FDA’s 505(b)(2) regulatory pathway.
(7) Based in Salt Lake City, UT, Amedica (AMDA) scheduled a $35 million IPO on the Nasdaq with a market capitalization of $125 million at a price range midpoint of $11 for Wednesday, February 12, 2014.
AMDA is a commercial biomaterial company focused on using its silicon nitride technology platform to develop, manufacture and sell a broad range of medical devices.
(8) Based in Portland, OR, Semler Scientific (SMLR) scheduled a $15 million IPO on the Nasdaq with a market capitalization of $62 million at a price range midpoint of $13 for Friday, February 14, 2014.
SMLR has a patented blood pressure cuff for extremities, to help diagnose cardiovascular problems.
Read Next
